<![CDATA[Genmab — Juni 2022]]>Lille forsinkelse til CD20 MS konkurrent

]]>https://dev.proinvestor.com/forum/topic/399161/genmab-juni-2022RSS for NodeMon, 08 Jun 2026 10:32:30 GMTWed, 01 Jun 2022 01:39:30 GMT60<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 20:03:09 GMT]]>Super nyhed. Der er medvind på cykelstien for Genmab allerede fra starten af sommertouren. 🙂

]]>https://dev.proinvestor.com/forum/post/7655494https://dev.proinvestor.com/forum/post/7655494Thu, 30 Jun 2022 20:03:09 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 18:31:04 GMT]]>FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) https://www.healio.com/news/hematology-oncology/20220630/fda-warns-about-potential-elevated-risk-for-death-with-blood-cancer-therapy-durvelisib
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-possible-increased-risk-death-and-serious-side-effects-cancer-drug-copiktra#:~:text=The U.S. Food and Drug,found in the lymph nodes.

]]>https://dev.proinvestor.com/forum/post/7655492https://dev.proinvestor.com/forum/post/7655492Thu, 30 Jun 2022 18:31:04 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 17:50:18 GMT]]>Normalt indsendes BLA’en vel 3 måneder efter topline data, når det går hurtigt. Så dejligt de henter mere tid.

]]>https://dev.proinvestor.com/forum/post/7655489https://dev.proinvestor.com/forum/post/7655489Thu, 30 Jun 2022 17:50:18 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 17:31:31 GMT]]>Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the https://www.proinvestor.com/investornyt/844797/genmab-to-submit-biologics-license-application-to-us-food-and-drug-administration-for-epcoritamab-duobody-cd3xcd20-for-the

]]>https://dev.proinvestor.com/forum/post/7655493https://dev.proinvestor.com/forum/post/7655493Thu, 30 Jun 2022 17:31:31 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 17:30:53 GMT]]>Fedt. 🙂

]]>https://dev.proinvestor.com/forum/post/7655487https://dev.proinvestor.com/forum/post/7655487Thu, 30 Jun 2022 17:30:53 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 17:30:01 GMT]]>Nu bekræfter de at de gav ok til ansøgning. Dejlig nyhed !

]]>https://dev.proinvestor.com/forum/post/7655484https://dev.proinvestor.com/forum/post/7655484Thu, 30 Jun 2022 17:30:01 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 17:29:20 GMT]]>Det sidste vi hørte til epco var, at de ville tale med myndighederne om det videre
forløb.

]]>https://dev.proinvestor.com/forum/post/7655483https://dev.proinvestor.com/forum/post/7655483Thu, 30 Jun 2022 17:29:20 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 17:23:59 GMT]]>Da man ansøgte Tisotumab Vedotin kom selskabsmeddelelsen først da FDA havde accepteret ansøgningen.

]]>https://dev.proinvestor.com/forum/post/7655485https://dev.proinvestor.com/forum/post/7655485Thu, 30 Jun 2022 17:23:59 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:48:56 GMT]]>Man vurderer, at markedet skal informeres om væsentlige forhold

]]>https://dev.proinvestor.com/forum/post/7655486https://dev.proinvestor.com/forum/post/7655486Thu, 30 Jun 2022 16:48:56 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:48:53 GMT]]>Måske for at komme før Roche?

]]>https://dev.proinvestor.com/forum/post/7655490https://dev.proinvestor.com/forum/post/7655490Thu, 30 Jun 2022 16:48:53 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:45:33 GMT]]>Lidt pudsigt at man annoncerer, at man har til hensigt at indsende ansøgning. Plejer man ikke at vente til ansøgningen sendes?

]]>https://dev.proinvestor.com/forum/post/7655481https://dev.proinvestor.com/forum/post/7655481Thu, 30 Jun 2022 16:45:33 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:43:16 GMT]]>https://firstwordpharma.com/story/5604815?t=eyJhbGciOiJBMjU2S1ciLCJlbmMiOiJBMjU2Q0JDLUhTNTEyIiwiemlwIjoiREVGIn0.gAEQAc1Sx_ZqFS4sq4mAbY4gELoQavWBZMUG1XoH0EWiZuAg4MLciuBwihOulBaUa8I5E8m8q9R0nUZQvEOcI5BKKYMH009g.cT1fv8LIzlC51k-yDPeolw.g2rOyHEMwOc44yTrxklZDzsFxSe2xTnUySMn0zJgzIcxQxTU2NtvYapchQ1qOGxwaCk063l_1tkAlLPoLTIjjvt8NESarxVrEpcDf7yuEe43iIpkCSVSbrp4px2ZoUkhqZF1FqES6P9vhdwOtRbuVP5zXK2et3AvG4pM9EMaC0mZlNJbaIduKoDHiXsiCsWq.MWRVXY5Bpmx3yF4GJIT7BHMgCaBD22UosdycnAP8hIU&nle=33117&aid=5604815&nlc=71

]]>https://dev.proinvestor.com/forum/post/7655488https://dev.proinvestor.com/forum/post/7655488Thu, 30 Jun 2022 16:43:16 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:39:43 GMT]]>Thx´

]]>https://dev.proinvestor.com/forum/post/7655491https://dev.proinvestor.com/forum/post/7655491Thu, 30 Jun 2022 16:39:43 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:39:04 GMT]]>cheers 🙂

]]>https://dev.proinvestor.com/forum/post/7655476https://dev.proinvestor.com/forum/post/7655476Thu, 30 Jun 2022 16:39:04 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:33:52 GMT]]>Jeg holder en lille fest for mig selv 🙂

]]>https://dev.proinvestor.com/forum/post/7655478https://dev.proinvestor.com/forum/post/7655478Thu, 30 Jun 2022 16:33:52 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 16:27:05 GMT]]>Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

]]>https://dev.proinvestor.com/forum/post/7655477https://dev.proinvestor.com/forum/post/7655477Thu, 30 Jun 2022 16:27:05 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 14:39:16 GMT]]>USA/middag: Aktier ramt af recessionsfrygt - værste halvår siden 1970 https://www.proinvestor.com/investornyt/844764/usa-middag-aktier-ramt-af-recessionsfrygt-vaerste-halvar-siden-1970

]]>https://dev.proinvestor.com/forum/post/7655479https://dev.proinvestor.com/forum/post/7655479Thu, 30 Jun 2022 14:39:16 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:12:17 GMT]]>Med reference til aktietilbagekøb i 2021, steg kursen til ca. 2600 fra 1900 over 4 måneder, hvor der blev tilbagekøbt 200.000 aktier.... Nu skal der købes 370.000 og den gennemsnitlige handelsvolumen er umiddelbare lavere disse dage sammenlignet med 2021

]]>https://dev.proinvestor.com/forum/post/7655480https://dev.proinvestor.com/forum/post/7655480Thu, 30 Jun 2022 13:12:17 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:10:14 GMT]]>Stoclbull og BSinvest har et kortsigtet teknisk kursmål på 2630. Er tilfreds hvis vi havner der den første august.

]]>https://dev.proinvestor.com/forum/post/7655482https://dev.proinvestor.com/forum/post/7655482Thu, 30 Jun 2022 13:10:14 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:04:39 GMT]]>Men volumen kom da over 100k. Mere end 1/3 i luk.

]]>https://dev.proinvestor.com/forum/post/7655474https://dev.proinvestor.com/forum/post/7655474Thu, 30 Jun 2022 13:04:39 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:04:38 GMT]]>Stroka..Så vidt jeg husker har Genmab i 2019, 2020 og 2021 steget flot hen over sommeren. Vi krydser fingre for en gentagelse i 2022.

]]>https://dev.proinvestor.com/forum/post/7655473https://dev.proinvestor.com/forum/post/7655473Thu, 30 Jun 2022 13:04:38 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:02:46 GMT]]>ca. 450 point over 14 dage er vel også godkendt med mindre nohope skal vurdere

]]>https://dev.proinvestor.com/forum/post/7655472https://dev.proinvestor.com/forum/post/7655472Thu, 30 Jun 2022 13:02:46 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:02:35 GMT]]>Mærkelig aktie 🙂

]]>https://dev.proinvestor.com/forum/post/7655475https://dev.proinvestor.com/forum/post/7655475Thu, 30 Jun 2022 13:02:35 GMT<![CDATA[Reply to Genmab — Juni 2022 on Thu, 30 Jun 2022 13:00:18 GMT]]>Det var da tæt på. 2297.

]]>https://dev.proinvestor.com/forum/post/7655470https://dev.proinvestor.com/forum/post/7655470Thu, 30 Jun 2022 13:00:18 GMT